Publikationen, an denen er mitarbeitet Cecilio Jesús Vidal Moreno (69)

2017

  1. Lipid rafts of mouse liver contain nonextended and extended acetylcholinesterase variants along with M3 muscarinic receptors

    FASEB Journal, Vol. 31, Núm. 2, pp. 544-555

2016

  1. Cholinergic system and cell proliferation

    Chemico-Biological Interactions, Vol. 259, pp. 257-265

  2. mRNA levels of ACh-related enzymes in the hippocampus of THY-Tau22 mouse: A model of human tauopathy with no signs of motor disturbance

    Journal of Molecular Neuroscience, Vol. 58, Núm. 4, pp. 411-415

2015

  1. Acetylcholinesterase activity of electric eel is increased or decreased by selected monoterpenoids and phenylpropanoids in a concentration-dependent manner

    Chemico-Biological Interactions, Vol. 229, pp. 36-43

  2. Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma

    BMC Cancer, Vol. 15, Núm. 1

  3. Unbalanced acetylcholinesterase activity in larynx squamous cell carcinoma

    International Immunopharmacology, Vol. 29, Núm. 1, pp. 81-86

2014

  1. Most acetylcholinesterase activity of non-nervous tissues and cells arises from the AChE-H transcript

    Journal of Molecular Neuroscience, Vol. 53, Núm. 3, pp. 429-435

  2. The lipid raft-bound alkaline phosphatase activity increases and the level of transcripts remains unaffected in liver of merosin-deficient LAMA2dy mouse

    Chemico-Biological Interactions, Vol. 216, Núm. 1, pp. 1-8

2013

  1. The AChE membrane-binding tail PRiMA is down-regulated in muscle and nerve of mice with muscular dystrophy by merosin deficiency

    Chemico-Biological Interactions

2012

  1. Changes in the expression and structure of cholinesterases in excitable and non-excitable tissues of the merosin-deficient Lama2dy mouse, a model of congenital muscular dystrophy

    Cholinesterase: Production, Uses and Health Effects (Nova Science Publishers, Inc.), pp. 1-32

2010

  1. Cholinesterase activity in brain of senescence-accelerated-resistant mouse SAMR1 and its variation in brain of senescence-accelerated-prone mouse SAMP8

    Journal of Neuroscience Research, Vol. 88, Núm. 1, pp. 155-166

  2. Expression of cholinesterases in human kidney and its variation in renal cell carcinoma types

    FEBS Journal, Vol. 277, Núm. 21, pp. 4519-4529

  3. The levels of both lipid rafts and raft-located acetylcholinesterase dimers increase in muscle of mice with muscular dystrophy by merosin deficiency

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1802, Núm. 9, pp. 754-764

2009

  1. Hydrolysis of acetylthiocoline, o-nitroacetanilide and o- nitrotrifluoroacetanilide by fetal bovine serum acetylcholinesterase

    FEBS Journal, Vol. 276, Núm. 7, pp. 2074-2083

2008

  1. Human butyrylcholinesterase components differ in aryl acylamidase activity

    Biological Chemistry, Vol. 389, Núm. 4, pp. 425-432

  2. Targeting of acetylcholinesterase to lipid rafts of muscle

    Chemico-Biological Interactions, Vol. 175, Núm. 1-3, pp. 312-317

  3. The expression of cholinesterases in human renal tumours varies according to their histological types

    Chemico-Biological Interactions, Vol. 175, Núm. 1-3, pp. 340-342

  4. The level of aryl acylamidase activity displayed by human butyrylcholinesterase depends on its molecular distribution

    Chemico-Biological Interactions, Vol. 175, Núm. 1-3, pp. 336-339

  5. The level of butyrylcholinesterase activity increases and the content of the mRNA remains unaffected in brain of senescence-accelerated mouse SAMP8

    Chemico-Biological Interactions, Vol. 175, Núm. 1-3, pp. 332-335

2007

  1. Butyrylcholinesterase activity and molecular components in thymus of healthy and merosin-deficient Lama2dy mice

    Neurochemistry International, Vol. 50, Núm. 3, pp. 531-539